Skip to content

Refractive Outcomes and Ocular Biometry of Two Swept-Source Optical Coherence Tomography-Based Biometers With Segmental or Equivalent Refractive Indices (ORION)

Refractive Outcomes and Ocular Biometry of Two Swept-Source Optical Coherence Tomography-Based Biometers With Segmental or Equivalent Refractive Indices (ORION): A Non-Inferiority Randomized Clinical Trials

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06377007
Acronym
ORION
Enrollment
144
Registered
2024-04-22
Start date
2024-05-01
Completion date
2025-01-31
Last updated
2026-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract

Keywords

Biometry, SS-OCT, IOLMaster700, Argos

Brief summary

This prospective, single-centre, randomized, parallel-group comparative clinical study evaluated the refractive prediction accuracy of two swept-source optical coherence tomography (SS-OCT) biometers in a Thai cataract surgery cohort. The ARGOS biometer applies segmental refractive indices to individual ocular segments, whereas the IOLMaster 700 applies an equivalent refractive index to the whole eye. Each device is conventionally paired with a different keratometry-formula combination: ARGOS with the standard Barrett Universal II (Barrett UII K), and IOLMaster 700 with the Barrett Universal II using total keratometry (Barrett UII TK). The study compared these two device-formula pairings as they are used in routine clinical practice. Both biometers were performed on every eye on the same day, enabling a within-subject paired comparison of biometric agreement and refractive prediction error at one month after phacoemulsification cataract surgery with implantation of a TECNIS Monofocal one-piece IOL (model GCB00V)

Detailed description

One hundred and forty-four eyes of 144 consecutive Thai cataract surgery patients aged 40-90 years presenting with visually significant age-related cataract were enrolled at the Ophthalmology Service, Walailak University Hospital between May 2024 and December 2024. Participants underwent preoperative biometric measurement on the same day with both the ARGOS (software version A2.4; Movu, Inc., a Santec company; distributed by Alcon Laboratories) and the IOLMaster 700 (software version 1.90.10; Carl Zeiss Meditec AG) by a single experienced operator. Participants were randomized 1:1 between two IOL-selection arms using a computer-generated allocation sequence (Research Randomizer, blocks of 12): Group 1 used the IOLMaster 700 with the Barrett Universal II TK formula for IOL power selection, and Group 2 used the ARGOS with the standard Barrett Universal II K formula. Allocation was concealed from the enrolling surgeon until completion of preoperative biometry. Participants were masked to the device-formula arm. All cataract surgeries were performed by four experienced surgeons (in approximately equal numbers) using a standardized phacoemulsification technique with in-the-bag implantation of the TECNIS Monofocal one-piece IOL (model GCB00V; Johnson & Johnson Vision). The primary outcome was mean absolute prediction error (MAE) at one month postoperatively, assessed by a masked refractionist using subjective manifest refraction. Secondary outcomes were median absolute prediction error and the proportion of eyes within ±0.25 D and ±0.50 D of target refraction. One eye per patient was enrolled. The study was registered prospectively as a non-inferiority trial; the implemented analysis is reported as a within-subject paired comparative analysis with descriptive accuracy thresholds rather than as a formal non-inferiority hypothesis test (CONSORT item 3b). The total enrolled sample was 144 patients; within-subject paired analyses included 138 eyes with complete data for both devices.

Interventions

DEVICEARGOS (Movu/Santec; distributed by Alcon)

Preoperative biometric measurement using the ARGOS (software version A2.4). IOL power was calculated using the Barrett Universal II K formula and used for power selection in this arm.

DEVICEIOLMaster 700 (Carl Zeiss Meditec AG)

Preoperative biometric measurement using the IOLMaster 700 (software version 1.90.10). IOL power was calculated using the Barrett Universal II TK formula and used for power selection in this arm.

Sponsors

Walailak University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
40 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

• Adults aged 40-90 years presenting with visually significant age-related cataract scheduled for elective phacoemulsification with implantation of a TECNIS Monofocal one-piece IOL (model GCB00V).

Exclusion criteria

* Corneal astigmatism greater than 1.00 D on either device * Central corneal thickness outside 490-600 µm * Severe dry eye precluding reliable keratometry * Rigid or soft contact lens wear within 2 months prior to evaluation * Previous corneal refractive surgery or other corneal pathology * Prior intraocular surgery (other than uneventful cataract surgery in the fellow eye) * Clinically significant retinal pathology potentially affecting refractive outcome (e.g., epiretinal membrane, diabetic macular edema, advanced age-related macular degeneration) * Intraoperative complications including posterior capsule rupture, vitreous loss, or zonular dehiscence * Dense cataract that does not allow measurements with optical biometry * Inability to attend follow-up

Design outcomes

Primary

MeasureTime frameDescription
Mean absolute prediction error4 weeksMean absolute prediction error determining by the absolute disparity between the predicted spherical equivalent refraction derived from preoperative planning and the actual measured spherical equivalent refraction (manifest) from both devices (IOLMaster 700 and Argos)

Secondary

MeasureTime frameDescription
Median absolute prediction error4 weeksMedian of the absolute differences between predicted spherical equivalent refraction (derived from preoperative biometry and IOL formula) and the actual measured spherical equivalent (manifest refraction) at one month postoperatively, for both devices (IOLMaster 700 with Barrett UII TK and ARGOS with Barrett UII K)
Proportion of eyes within ±0.50 D of target refraction4 weeksPercentage of eyes in which the absolute prediction error was within ±0.50 D of the target refraction at one month postoperatively, for each device-formula pairing.
Proportion of eyes with absolute prediction error ≤ 0.25 D4 weeksPercentage of eyes in which the absolute prediction error (\|measured SE - predicted SE\|) was within ±0.25 D of the target refraction at one month postoperatively, for each device-formula pairing.

Countries

Thailand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 16, 2026